Fast Forward Pharmaceuticals BV
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Fast Forward Pharmaceuticals BV
Can Merck Serono Bounce Back?
Merck KGAA’s $13 billion acquisition of Serono in 2006 created an unwieldy pharmaceutical organization further hobbled by expensive clinical setbacks. Seven years later, driven by new leadership, it is in the midst of an overdue transformation.
Fast Forward And Myelin Repair Foundation: Two Routes To New MS Drugs
Despite the availability of new oral medicines, larger advances in MS remain elusive, especially for those with advanced MS. Two nonprofit groups, the National MS Society’s Fast Forward venture arm and the Myelin Repair Foundation, are thinking creatively in different ways – but both spending millions of dollars – to make those breakthroughs come sooner.
Recent Tech Transfer Deals (4/2009)
Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.
- Other Names / Subsidiaries
- FF Pharma
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.